PASS-ASSISTED PREDICTION OF NOVEL TETRACYCLINE HYBRIDS

Authors

  • MANSI SHAH Faculty of Pharmacy, Dharamsinh Desai University, Nadiad-387001, Gujarat, India. Department of Pharmacology, L.J. Institute of Pharmacy, LJ University, Ahmedabad, Gujarat, India https://orcid.org/0000-0002-7000-5865
  • BHANUBHAI SUHAGIA Faculty of Pharmacy, Dharamsinh Desai University, Nadiad-387001, Gujarat, India
  • SUNITA GOSWAMI L.M. College of Pharmacy, Ahmedabad-380009, Gujarat, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i6.6011

Keywords:

Tetracycline hybrids, Hybridization, PASS software

Abstract

Objective: The study aimed to determine the biological activity of various novel tetracycline hybrids using way 2 drug platform's online pass software.

Methods: Novel structures were designed computationally by hybridization of 9-amino tetracycline with various phyotchemicals using various covalent linkers and prediction of biological activity was done using online pass software.

Results: The study investigated showed the antibacterial activity of almost all hybridized tetracycline compounds. The PASS predictions suggested that modifications at the 9th position of tetracycline with various phytochemicals enhanced the antibacterial activity or retained the antibacterial activity for several of the designed structures when compared with standard tetracycline.

Conclusion: With an alarming increase of antibiotic resistance, we must identify ways to combat these diseases. This work implies that combining antimicrobials with phytochemicals can create new antimicrobial-photochemical conjugates, potentially addressing antimicrobial resistance in bacteria. Tetracycline hybrids can be used in the future to produce many more hybrids, potentially embarking in a new era of medicine research.

Downloads

Download data is not yet available.

References

Yadav M, Lal K, Kumar A, Kumar A, Kumar D. Indole chalcone linked 1,2,3-triazole hybrids: facile synthesis antimicrobial evaluation and docking studies as potential antimicrobial agents. J Mol Struct. 2022;1261(5):132867. doi: 10.1016/j.molstruc.2022.132867.

DE Oliveira DM, Forde BM, Kidd TJ, Harris PN, Schembri MA, Beatson SA. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181-19. doi: 10.1128/CMR.00181-19, PMID 32404435.

Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev. 2005;57(10):1486-513. doi: 10.1016/j.addr.2005.04.004, PMID 15939505.

Klahn P, Bronstrup M. Bifunctional antimicrobial conjugates and hybrid antimicrobials. Nat Prod Rep. 2017;34(7):832-85. doi: 10.1039/c7np00006e, PMID 28530279.

Zhivich A. Fighting bacterial resistance: approaches challenges and opportunities in the search for new antibiotics part 1 antibiotics used in clinical practice: mechanisms of action and the development of bacterial resistance. Microbiology Independent Research Journal. 2017;4(1):31-51. doi: 10.18527/2500-2236-2017-4-1-31-51.

Kumar L, Lal K, Kumar A, Paul AK, Kumar A. Pyrazoline tethered 1,2,3-triazoles: synthesis antimicrobial evaluation and in silico studies. Journal of Molecular Structure. 2021 Dec 15;1246:131154. doi: 10.1016/j.molstruc.2021.131154.

Mohammed HH, Ali DM, Badr M, Habib AG, Mahmoud AM, Farhan SM. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors. Mol Divers. 2023;27(4):1751-65. doi: 10.1007/s11030-022-10528-z, PMID 36152132.

Kuppusamy R, Browne K, Suresh D, DO Rosario RM, Chakraborty S, Yang S. Transition towards antibiotic hybrid vehicles: the next generation antibacterials. Curr Med Chem. 2022;30(1):104-25. doi: 10.2174/0929867329666220613105424, PMID 35702780.

Miller JR, Waldrop GL. Discovery of novel antibacterials. Expert Opin Drug Discov. 2010;5(2):145-54. doi: 10.1517/17460440903493449, PMID 22822914.

Parkes AL, Yule IA. Hybrid antibiotics clinical progress and novel designs. Expert Opin Drug Discov. 2016;11(7):665-80. doi: 10.1080/17460441.2016.1187597, PMID 27169483.

Pokrovskaya V, Baasov T. Dual acting hybrid antibiotics: a promising strategy to combat bacterial resistance. Expert Opin Drug Discov. 2010;5(9):883-902. doi: 10.1517/17460441.2010.508069, PMID 22823262.

Grossman TH. Tetracycline antibiotics and resistance. Cold Spring Harb Perspect Med. 2016;6(4):a025387. doi: 10.1101/cshperspect.a025387, PMID 26989065.

Usai I, Krueger M, Einsiedel J, Hillen W, Gmeiner P. Click chemistry derived tetracycline amino acid conjugates exhibiting exceptional potency and exclusive recognition of the reverse tet repressor. Chembiochem. 2010;11(5):703-12. doi: 10.1002/cbic.200900710, PMID 20148427.

Tietze LF, Bell HP, Chandrasekhar S. Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed Engl. 2003;42(34):3996-4028. doi: 10.1002/anie.200200553, PMID 12973759.

Filimonov DA, Druzhilovskiy DS, Lagunin AA, Gloriozova TA, Rudik AV, Dmitriev AV. Computer-aided prediction of biological activity spectra for chemical compounds: opportunities and limitations. Biomed Chem Res Methods. 2018;1(1):e00004. doi: 10.18097/BMCRM00004.

Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Comp. 2014;50(3):444-57. doi: 10.1007/s10593-014-1496-1.

Poroikov VV, Filimonov DA, Borodina YV, Lagunin AA, Kos A. Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds. J Chem Inf Comput Sci. 2000;40(6):1349-55. doi: 10.1021/ci000383k, PMID 11128093.

Sucularlı C, Tozkoparan B, Aytac SP. In silico activity and target prediction analyses of three triazolothiadiazine derivatives. Acta Med. 2022;53(3):251-60. doi: 10.32552/2022.ActaMedica.737.

Bocharova OA, Ionov NS, Kazeev IV, Shevchenko VE, Bocharov EV, Karpova RV. Computer-aided evaluation of polyvalent medications pharmacological potential multiphytoadaptogen as a case study. Mol Inform. 2023;42(1):e2200176. doi: 10.1002/minf.202200176, PMID 36075866.

Arabi II, Kawsar SM. In silico investigations of some carbohydrate derivatives: pass prediction ADMET QSAR and molecular docking studies against pseudomonas aeruginosa. Philipp J Sci. 2023;152(4):1397-412. doi: 10.56899/152.04.11.

Stepanchikova AV, Lagunin AA, Filimonov DA, Poroikov VV. Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. Curr Med Chem. 2003;10(3):225-33. doi: 10.2174/0929867033368510, PMID 12570709.

Basanagouda M, Jadhav VB, Kulkarni MV, Rao RN. Computer-aided prediction of biological activity spectra: study of correlation between predicted and observed activities for coumarin-4-acetic acids. Indian J Pharm Sci. 2011;73(1):88-92. doi: 10.4103/0250-474X.89764, PMID 22131629.

Zhang J, Ponomareva LV, Marchillo K, Zhou M, Andes DR, Thorson JS. Synthesis and antibacterial activity of doxycycline neoglycosides. J Nat Prod. 2013;76(9):1627-36. doi: 10.1021/np4003096, PMID 23987662.

Published

15-11-2024

How to Cite

SHAH, M., B. SUHAGIA, and S. GOSWAMI. “PASS-ASSISTED PREDICTION OF NOVEL TETRACYCLINE HYBRIDS”. International Journal of Current Pharmaceutical Research, vol. 16, no. 6, Nov. 2024, pp. 45-61, doi:10.22159/ijcpr.2024v16i6.6011.

Issue

Section

Original Article(s)